Clinical

Dataset Information

0

Clinical effectiveness of daikenchuto (TJ-100) on gastrointestinal symptom after colectomy in colorectal cancer patients with abdominal pain and distention due to a bowel movement disorder.


ABSTRACT: Interventions: Oral administration of test drug (daikenchuto) 5.0 g per dose as a general rule (15 g/day, t.i.d., before meals) from patiant consent day to preoperative day and postoperative day 2 to postoperative day 28. Standard of care. Primary outcome(s): 1) Gastrointestinal symptom. (abdominal pain /distention/ the sensation of incomplete bowel evacuation)2) number of postoperative day to comfirm first evacuation, number of postoperative time to comfirm first flatus, number of bowel movements per day. Study Design: Parallel Randomized

DISEASE(S): Colorectal Cancer Patients With Abdominal Pain And Distention Due To A Bowel Movement Disorder

PROVIDER: 2623756 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2018-02-27 | GSE102962 | GEO
2022-05-06 | GSE202166 | GEO
2021-08-30 | PXD005219 | Pride
2015-06-01 | GSE65881 | GEO
2023-11-27 | PXD046496 | Pride
| 2080253 | ecrin-mdr-crc
| PRJNA1058544 | ENA
| PRJNA1094905 | ENA
2021-11-04 | GSE187544 | GEO
| 114147 | ecrin-mdr-crc